JP2024542260A5 - - Google Patents

Info

Publication number
JP2024542260A5
JP2024542260A5 JP2024530522A JP2024530522A JP2024542260A5 JP 2024542260 A5 JP2024542260 A5 JP 2024542260A5 JP 2024530522 A JP2024530522 A JP 2024530522A JP 2024530522 A JP2024530522 A JP 2024530522A JP 2024542260 A5 JP2024542260 A5 JP 2024542260A5
Authority
JP
Japan
Prior art keywords
branched
independently
unbranched
compound according
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024530522A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024542260A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/050725 external-priority patent/WO2023091787A1/en
Publication of JP2024542260A publication Critical patent/JP2024542260A/ja
Publication of JP2024542260A5 publication Critical patent/JP2024542260A5/ja
Pending legal-status Critical Current

Links

JP2024530522A 2021-11-22 2022-11-22 新規イオン化可能な脂質および脂質ナノ粒子ならびにそれらを使用する方法 Pending JP2024542260A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163264420P 2021-11-22 2021-11-22
US202163264400P 2021-11-22 2021-11-22
US63/264,420 2021-11-22
US63/264,400 2021-11-22
US202263322952P 2022-03-23 2022-03-23
US63/322,952 2022-03-23
PCT/US2022/050725 WO2023091787A1 (en) 2021-11-22 2022-11-22 Novel ionizable lipids and lipid nanoparticles and methods of using the same

Publications (2)

Publication Number Publication Date
JP2024542260A JP2024542260A (ja) 2024-11-13
JP2024542260A5 true JP2024542260A5 (cg-RX-API-DMAC7.html) 2025-11-28

Family

ID=84888584

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024530522A Pending JP2024542260A (ja) 2021-11-22 2022-11-22 新規イオン化可能な脂質および脂質ナノ粒子ならびにそれらを使用する方法

Country Status (8)

Country Link
US (1) US20250051263A1 (cg-RX-API-DMAC7.html)
EP (1) EP4436549A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024542260A (cg-RX-API-DMAC7.html)
KR (1) KR20240128683A (cg-RX-API-DMAC7.html)
AU (1) AU2022391677A1 (cg-RX-API-DMAC7.html)
CA (1) CA3238758A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024006134A (cg-RX-API-DMAC7.html)
WO (1) WO2023091787A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202348600A (zh) * 2022-06-06 2023-12-16 大陸商上海藍鵲生物醫藥有限公司 含氮鏈狀化合物、製備方法、包含其的組成物和應用
JP2025534494A (ja) * 2022-12-23 2025-10-15 グリーン・クロス・コーポレイション イオン化可能な脂質及びその使用
US20260116844A1 (en) * 2022-12-29 2026-04-30 SurgiNex Co., Ltd. Lipid nanoparticle formulation comprising ionized lipids with branched structure, and use thereof
CN116178193B (zh) * 2023-01-05 2023-07-28 北京悦康科创医药科技股份有限公司 高效低毒且稳定性表达的阳离子脂质化合物及其组合物
JP2026503676A (ja) * 2023-01-27 2026-01-29 セイル バイオメディシンズ インコーポレイテッド 修飾脂質組成物およびその使用
WO2024181917A1 (en) * 2023-02-28 2024-09-06 Agency For Science, Technology And Research A compound for preparing lipid nanoparticles encapsulating an agent, nanoparticle composition comprising said compound and related methods thereof
EP4719352A1 (en) 2023-05-31 2026-04-08 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions
EP4724419A1 (en) * 2023-06-06 2026-04-15 Agency for Science, Technology and Research A nanoparticle composition and related methods thereof
WO2025042786A1 (en) 2023-08-18 2025-02-27 Flagship Pioneering Innovations Vi, Llc Compositions comprising circular polyribonucleotides and uses thereof
AR134145A1 (es) * 2023-10-24 2025-12-03 Green Cross Corp Lípidos ionizables y sus usos
US12599560B2 (en) 2023-11-02 2026-04-14 Longuide Biopharma Corporation Lipids and lipid nanoparticle formulations
CN117919200B (zh) * 2024-01-19 2025-09-05 晟迪生物医药(苏州)有限公司 含有可电离脂质的肺部递送系统、其制备方法和应用
US20250381150A1 (en) 2024-03-08 2025-12-18 Genzyme Corporation Lipid nanoparticles
TW202539618A (zh) * 2024-04-02 2025-10-16 大陸商南京奧羅生物科技有限公司 可電離脂質化合物、包含其的脂質奈米顆粒及其應用
WO2026030375A2 (en) 2024-07-30 2026-02-05 Genzyme Corporation Lipid nanoparticles and methods of manufacture and use thereof
WO2026096919A1 (en) * 2024-11-01 2026-05-07 Sail Biomedicines, Inc. Novel dipepetide core lipids, lipid carriers, and methods of using thereof
WO2026142951A1 (en) 2024-12-23 2026-07-02 Genzyme Corporation Pharmaceutical system
WO2026152164A1 (en) 2025-01-13 2026-07-16 Sail Biomedicines, Inc. Cd5-targeted lipid nanoparticles encapsulating polyribonucleotides encoding chimeric antigen receptors, and methods to generate car-expressing t cells in vivo
WO2026165320A1 (en) * 2025-01-31 2026-08-06 Sanofi Vaccines US Inc. Morpholino cationic lipids

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US907699A (en) 1906-04-24 1908-12-22 William D Moore Building-block.
EP0079963B1 (en) 1981-06-04 1986-08-27 Delaware Chemicals Corporation Pressurized container with dispensing pump
US4778810A (en) 1987-01-08 1988-10-18 Nastech Pharmaceutical Co., Inc. Nasal delivery of caffeine
US6197553B1 (en) 1994-07-15 2001-03-06 Merck & Co., Inc. Method for large scale plasmid purification
US5965542A (en) 1997-03-18 1999-10-12 Inex Pharmaceuticals Corp. Use of temperature to control the size of cationic liposome/plasmid DNA complexes
JP2002502831A (ja) 1998-02-03 2002-01-29 イネックス ファーマシューティカルズ コーポレイション 癌の治療に用いる血清に対して安定なプラスミド脂質粒子の全身供与
US6410328B1 (en) 1998-02-03 2002-06-25 Protiva Biotherapeutics Inc. Sensitizing cells to compounds using lipid-mediated gene and compound delivery
US6211140B1 (en) 1999-07-26 2001-04-03 The Procter & Gamble Company Cationic charge boosting systems
EP1519714B1 (en) 2002-06-28 2010-10-20 Protiva Biotherapeutics Inc. Method and apparatus for producing liposomes
AU2004257373B2 (en) 2003-07-16 2011-03-24 Arbutus Biopharma Corporation Lipid encapsulated interfering RNA
US6927663B2 (en) 2003-07-23 2005-08-09 Cardiac Pacemakers, Inc. Flyback transformer wire attach method to printed circuit board
CN1882693B (zh) 2003-09-15 2012-08-15 普洛体维生物治疗公司 聚乙二醇修饰的脂质化合物及其应用
US7745651B2 (en) 2004-06-07 2010-06-29 Protiva Biotherapeutics, Inc. Cationic lipids and methods of use
CA2569664C (en) 2004-06-07 2013-07-16 Protiva Biotherapeutics, Inc. Lipid encapsulated interfering rna
JP5639338B2 (ja) 2005-07-27 2014-12-10 プロチバ バイオセラピューティクス インコーポレイティッド リポソームの製造システムおよび製造方法
EP3100718B1 (en) 2008-01-02 2019-11-27 Arbutus Biopharma Corporation Improved compositions and methods for the delivery of nucleic acids
EP2279254B1 (en) 2008-04-15 2017-07-05 Protiva Biotherapeutics Inc. Novel lipid formulations for nucleic acid delivery
EP3699172A3 (en) 2008-11-10 2020-11-18 Arbutus Biopharma Corporation Novel lipids and compositions for the delivery of therapeutics
US8569256B2 (en) 2009-07-01 2013-10-29 Protiva Biotherapeutics, Inc. Cationic lipids and methods for the delivery of therapeutic agents
ES2613498T3 (es) 2009-07-01 2017-05-24 Protiva Biotherapeutics Inc. Nuevas formulaciones de lípidos para el suministro de agentes terapéuticos a tumores sólidos
WO2011066651A1 (en) 2009-12-01 2011-06-09 Protiva Biotherapeutics, Inc. Snalp formulations containing antioxidants
CA3044884A1 (en) 2009-12-07 2011-06-16 Arbutus Biopharma Corporation Compositions for nucleic acid delivery
US20130017223A1 (en) 2009-12-18 2013-01-17 The University Of British Columbia Methods and compositions for delivery of nucleic acids
US20130123338A1 (en) 2010-05-12 2013-05-16 Protiva Biotherapeutics, Inc. Novel cationic lipids and methods of use thereof
EP4481047A3 (en) 2010-06-03 2025-04-16 Alnylam Pharmaceuticals, Inc. Biodegradable lipids for the delivery of active agents
WO2012016184A2 (en) 2010-07-30 2012-02-02 Alnylam Pharmaceuticals, Inc. Methods and compositions for delivery of active agents
US8466122B2 (en) 2010-09-17 2013-06-18 Protiva Biotherapeutics, Inc. Trialkyl cationic lipids and methods of use thereof
US9999673B2 (en) 2011-01-11 2018-06-19 Alnylam Pharmaceuticals, Inc. PEGylated lipids and their use for drug delivery
CA2831613A1 (en) 2011-03-31 2012-10-04 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
US8691750B2 (en) 2011-05-17 2014-04-08 Axolabs Gmbh Lipids and compositions for intracellular delivery of biologically active compounds
WO2013016058A1 (en) 2011-07-22 2013-01-31 Merck Sharp & Dohme Corp. Novel bis-nitrogen containing cationic lipids for oligonucleotide delivery
JP6250543B2 (ja) 2011-09-27 2017-12-20 アルニラム・ファーマシューティカルズ・インコーポレーテッド ジ脂肪族置換peg化脂質
US8762704B2 (en) 2011-09-29 2014-06-24 Apple Inc. Customized content for electronic devices
WO2013086322A1 (en) 2011-12-07 2013-06-13 Alnylam Pharmaceuticals, Inc. Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents
US20140308304A1 (en) 2011-12-07 2014-10-16 Alnylam Pharmaceuticals, Inc. Lipids for the delivery of active agents
DE21212055T1 (de) 2011-12-07 2022-08-04 Alnylam Pharmaceuticals, Inc. Biologisch abbaubare lipide zur freisetzung von wirkstoffen
ES2923757T3 (es) 2011-12-16 2022-09-30 Modernatx Inc Composiciones de ARNm modificado
US9415109B2 (en) 2012-07-06 2016-08-16 Alnylam Pharmaceuticals, Inc. Stable non-aggregating nucleic acid lipid particle formulations
CA2953341C (en) 2014-06-25 2023-01-24 Acuitas Therapeutics Inc. Lipids and lipid nanoparticle formulations for delivery of nucleic acids
HUE067372T2 (hu) 2015-06-29 2024-10-28 Acuitas Therapeutics Inc Lipidek és nanoszemcsés lipid formulázások nukleinsavak beadására
CN108368028B (zh) 2015-10-28 2021-09-03 爱康泰生治疗公司 用于递送核酸的新型脂质和脂质纳米颗粒制剂
US12678515B2 (en) 2015-12-30 2026-07-14 Acuitas Therapeutics, Inc. Lipids and lipid nanoparticle formulations for delivery of nucleic acids
WO2019036028A1 (en) * 2017-08-17 2019-02-21 Acuitas Therapeutics, Inc. LIPIDS FOR USE IN LIPID NANOPARTICULAR FORMULATIONS
CN113939282A (zh) 2019-01-31 2022-01-14 摩登纳特斯有限公司 制备脂质纳米颗粒的方法

Similar Documents

Publication Publication Date Title
JP2024542188A5 (cg-RX-API-DMAC7.html)
JP7594038B2 (ja) Rna送達のためのイオン化可能なカチオン性脂質
JP2024546952A5 (cg-RX-API-DMAC7.html)
EP3397614B1 (en) Ionizable cationic lipid
JP2024546951A5 (cg-RX-API-DMAC7.html)
US9365610B2 (en) Asymmetric ionizable cationic lipid for RNA delivery
JP2023541427A (ja) 骨格筋送達プラットフォーム及び使用方法
JP2022505234A5 (cg-RX-API-DMAC7.html)
JP2024542260A (ja) 新規イオン化可能な脂質および脂質ナノ粒子ならびにそれらを使用する方法
WO2016081029A1 (en) Ionizable cationic lipid for rna delivery
JP2022533069A5 (cg-RX-API-DMAC7.html)
JP2023541415A (ja) 治療薬の送達用脂質複合体
JP2023538524A5 (cg-RX-API-DMAC7.html)
JP2022087209A (ja) B型肝炎を治療するための治療用組成物及び方法
JP2023518944A5 (cg-RX-API-DMAC7.html)
CN115702005A (zh) 用于有效核酸递送的载体
JP2024512770A (ja) 遺伝子送達における非ウイルスベクターとしての樹状構造
RU2319692C2 (ru) Производные тетрагидрокарбазола, способ получения производных тетрагидрокарбазола (варианты), их применение (варианты) и фармацевтическая композиция, обладающая активностью антагониста гонадотропин-рилизинг-гормона (варианты)
JP2022539091A5 (cg-RX-API-DMAC7.html)
CN117897152A (zh) 含有糖官能化核酸载体的纳米颗粒组合物
WO2024094098A1 (zh) 一种用于递送系统的化合物及其用途
CN116490214A (zh) 骨骼肌递送平台及使用方法
JP2023533452A5 (cg-RX-API-DMAC7.html)
US20260078086A1 (en) Versatile biodegradable molecules as nucleic acid carriers
AU2024370360A1 (en) Novel gene delivery agents